All In Biotech

Drug Trial Radar · NCT06368986

A Study to Investigate the Effect of Food on the Bioavailability of a Capsid Inhibitor (CAI) in Male and Female Healthy Participants

An Open Label, Phase 1 Study to Assess the Effect of Food on Bioavailability for an Investigational Capsid Inhibitor in Healthy Adult Participants

Last checked: Nov 20, 2026Latest source record: Feb 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Apr 17, 2024

Primary completion

Oct 2, 2024

Study completion Oct 2, 2024

Sponsor

Lead sponsor
ViiV HealthcareGSK (GSK)
Sponsor type
Industry
First posted
Apr 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate effect of food (in fasted and fed conditions) on the bioavailability of CAI VH4011499.

Conditions

  • HIV Infections

Interventions

  • VH4011499 Dose ADrug

    VH4011499 administered in fasted or fed conditions.

  • VH4011499 Dose BDrug

    VH4011499 Dose B administered in fasted or fed conditions.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the plasma concentration - time curve from time zero (pre-dose) to infinity time (AUC[0-inf]) of VH4011499Time frame: From Day 1 (pre-dose) to Day 28
  2. Area under the plasma drug concentration - time curve from zero (pre-dose) to the end of the dosing interval at steady state (AUC[0-tlast) of VH4011499Time frame: From Day 1 (pre-dose) to Day 28
  3. Maximum observed plasma drug concentration (Cmax) of VH4011499Time frame: From Day 1 (pre-dose) to Day 28
  4. Time to maximum observed plasma concentration (Tmax) of VH4011499Time frame: From Day 1 (pre-dose) to Day 28

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.